Metabolic Biomarkers
Loews Philadelphia Hotel
1200 Market Street
Philadelphia, PA

Schedule of Presentations:

Monday, September 29, 2008
07:00:00 Registration for Pre-Conference Events
08:00:00 Pre-Conference Tutorial* (*Separate Registration Required) Fit-for-Purpose Biomarker Assay Development and Validation Jean W Lee
08:00:00 Pre-Conference Workshop* (*Separate Registration Required) George A. Calin
08:30:00 miRNAs as Novel Biomarkers for Detecting Cervical Cancer Lymph Node Metastasis
09:00:00 Discovery of miRNA-Based Biomarkers for Cancer Søren Møller
09:30:00 Coffee Break
10:00:00 Her2/neu, microRNAs and Herceptin Michael N. Liebman
10:30:00 Evaluation of microRNAs for Diagnosis and Prognosis of Patients with Solid Tumors Mitch Raponi
12:00:00 New Presentation
12:00:00 New Presentation
Tuesday, September 30, 2008
08:00:00 Speeding Translation of Disease Marker Identification to Assay A Novel Label-Free Differential Analysis Work-Flow for Protein Biomarker Discovery from Tumor Tissue Interstitial Fluid –
08:00:00 Pre-Conference Workshop* (*Separate Registration Required)
08:30:00 Data-Independent LC-MS/MS Profiling of Unfractionated Serum
09:00:00 New Paradigm in Proteomics Biomarker Discovery and Evaluation
09:30:00 Large-Scale Discovery Based on Protein Separation: Case Study on Cardiac Disease
10:00:00 Coffee Break
10:30:00 MS-Based Quantitative Proteomics for Clinical Diagnosis
11:00:00 High-Throughput Cell-Based Studies and Protein Microarrays for Biomarker and Target Discovery Joshua LaBaer
11:30:00 Brain Damage Markers: From Discovery in the CSF to Validation in the Plasma
12:00:00 Lunch on your own
12:45:00 Differential Protein Expression Analysis Using Spectral Count Data in Label-Free Shotgun Proteomics
13:15:00 Mass Informatics of Mass Spectrometry-Based Protein Biomarker Discovery Xiang Yang Zhang
13:45:00 Refreshment Break
14:00:00 Proteomic Mapping of Vascular Biomarkers to Image Antibody Penetration into Single Organs and Solid Tumors Jan E Schnitzer
14:30:00 The Application of MALDI Mass Spectrometry Imaging (MALDI-MSI) to the Clinical Management of Prostate Cancer O. John Semmes
Wednesday, October 1, 2008
12:00:00 Pre-Conference Workshop* (*Separate Registration Required)
12:00:00 Occult Metastases Predict Recurrence Risk in Patients with pN0 Colorectal Cancer
12:30:00 Discovery and Validation of DNA Methylation-Based Biomarkers for Early Detection of Colorectal Cancer in Plasma
13:00:00 A Combinatorial Approach: The Use of MALDI-MS and Nano LC-MS for Glycan Biomarker Discovery
13:30:00 Refreshment Break
14:00:00 Overcoming Potential Pitfalls in the Detection of Circulating Tumor Cells in Blood by RT-PCR
14:30:00 Circulating Tumor DNA
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.